BioCryst Pharmaceuticals
BCRX
BCRX
103 hedge funds and large institutions have $501M invested in BioCryst Pharmaceuticals in 2018 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 25 increasing their positions, 36 reducing their positions, and 10 closing their positions.
Holders
103
Holders Change
–
Holders Change %
0%
% of All Funds
2.36%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
10
Increased
25
Reduced
36
Closed
10
Calls
$972K
Puts
$484K
Net Calls
+$488K
Net Calls Change
+$31K
Top Buyers
1 |
1
Janus Henderson Group
London,
United Kingdom
|
$63.6M |
2 |
2
D.E. Shaw & Co
New York
|
$9.36M |
3 |
3
BlackRock
New York
|
$44.4M |
4 |
VMI
4
VHCP Management II
New York
|
$14.1M |
5 |
5
Geode Capital Management
Boston,
Massachusetts
|
$5.75M |